| 0 |
HEPATIC NEOPLASM MALIGNANT NON-RESECTABLE |
1 |
0.0588 |
| 1 |
PANCREATIC NEUROENDOCRINE TUMOUR |
37 |
0.0577 |
| 2 |
CLONAL EVOLUTION |
4 |
0.0385 |
| 3 |
PORTAL VEIN EMBOLISM |
1 |
0.0385 |
| 4 |
BLOOD GLUCAGON INCREASED |
1 |
0.0217 |
| 5 |
SMALL INTESTINE NEUROENDOCRINE TUMOUR |
1 |
0.0182 |
| 6 |
RETROPERITONEAL CANCER |
1 |
0.0125 |
| 7 |
BLOOD CHROMOGRANIN A INCREASED |
5 |
0.0109 |
| 8 |
TUMOUR NECROSIS |
10 |
0.0095 |
| 9 |
GASTRIC ANTRAL VASCULAR ECTASIA |
5 |
0.0095 |
| 10 |
NEUROENDOCRINE CARCINOMA METASTATIC |
2 |
0.0081 |
| 11 |
INFECTED NEOPLASM |
2 |
0.0080 |
| 12 |
METASTASES TO THORAX |
2 |
0.0079 |
| 13 |
GALLBLADDER NEOPLASM |
1 |
0.0079 |
| 14 |
INSULINOMA |
1 |
0.0056 |
| 15 |
SERUM SEROTONIN INCREASED |
2 |
0.0056 |
| 16 |
TRICUSPID VALVE DISEASE |
2 |
0.0050 |
| 17 |
LIVER ABSCESS |
15 |
0.0046 |
| 18 |
PANCREATIC OPERATION |
1 |
0.0046 |
| 19 |
CONDUCTION DISORDER |
8 |
0.0044 |
| 20 |
NEUROENDOCRINE TUMOUR |
6 |
0.0042 |
| 21 |
PANCREATIC NEUROENDOCRINE TUMOUR METASTATIC |
1 |
0.0042 |
| 22 |
DUODENAL STENOSIS |
2 |
0.0041 |
| 23 |
RENAL ISCHAEMIA |
2 |
0.0037 |
| 24 |
LIVER OPERATION |
1 |
0.0032 |
| 25 |
THERAPEUTIC EMBOLISATION |
1 |
0.0032 |
| 26 |
PERFORMANCE STATUS DECREASED |
14 |
0.0030 |
| 27 |
CHOLANGITIS SCLEROSING |
5 |
0.0024 |
| 28 |
ANASTOMOTIC ULCER |
1 |
0.0022 |
| 29 |
ENCEPHALITIS |
15 |
0.0022 |
| 30 |
SHOCK HYPOGLYCAEMIC |
1 |
0.0021 |
| 31 |
METASTASES TO SPINE |
7 |
0.0021 |
| 32 |
COMPLEX REGIONAL PAIN SYNDROME |
3 |
0.0020 |
| 33 |
HYPERSPLENISM |
1 |
0.0020 |
| 34 |
LEFT VENTRICULAR DYSFUNCTION |
13 |
0.0019 |
| 35 |
MYELODYSPLASTIC SYNDROME TRANSFORMATION |
1 |
0.0019 |
| 36 |
REMISSION NOT ACHIEVED |
1 |
0.0016 |
| 37 |
FEMORAL NECK FRACTURE |
8 |
0.0016 |
| 38 |
NEPHROPATHY TOXIC |
17 |
0.0015 |
| 39 |
ABSCESS NECK |
1 |
0.0015 |
| 40 |
NEUROENDOCRINE CARCINOMA |
1 |
0.0014 |
| 41 |
HEPATIC PAIN |
6 |
0.0014 |
| 42 |
PULMONARY SEPSIS |
2 |
0.0014 |
| 43 |
CACHEXIA |
7 |
0.0014 |
| 44 |
CARCINOID TUMOUR |
1 |
0.0013 |
| 45 |
GLOMERULAR FILTRATION RATE INCREASED |
1 |
0.0012 |
| 46 |
CHOROIDAL NEOVASCULARISATION |
1 |
0.0012 |
| 47 |
DEVICE RELATED THROMBOSIS |
1 |
0.0010 |
| 48 |
ACUTE CORONARY SYNDROME |
8 |
0.0010 |
| 49 |
CD4 LYMPHOCYTES DECREASED |
2 |
0.0009 |
| 50 |
COMPRESSION FRACTURE |
5 |
0.0009 |
| 51 |
FAECES PALE |
2 |
0.0009 |
| 52 |
RENAL TUBULAR INJURY |
1 |
0.0008 |
| 53 |
METASTASES TO PERITONEUM |
2 |
0.0008 |
| 54 |
GLUCOSE URINE PRESENT |
1 |
0.0008 |
| 55 |
DRUG CLEARANCE DECREASED |
1 |
0.0008 |
| 56 |
RADICULOPATHY |
2 |
0.0008 |
| 57 |
PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME |
17 |
0.0007 |
| 58 |
CENTRAL NERVOUS SYSTEM LYMPHOMA |
1 |
0.0007 |
| 59 |
HYPOGLYCAEMIA |
35 |
0.0007 |
| 60 |
CARDIOTOXICITY |
6 |
0.0007 |
| 61 |
AGE-RELATED MACULAR DEGENERATION |
1 |
0.0007 |
| 62 |
INFECTIOUS PLEURAL EFFUSION |
1 |
0.0007 |
| 63 |
MOUTH ULCERATION |
13 |
0.0006 |
| 64 |
MALIGNANT NEOPLASM PROGRESSION |
63 |
0.0006 |
| 65 |
HEPATIC NEOPLASM |
2 |
0.0006 |
| 66 |
DEMENTIA ALZHEIMER'S TYPE |
1 |
0.0006 |
| 67 |
IMMUNE-MEDIATED LUNG DISEASE |
1 |
0.0005 |
| 68 |
LYMPH NODE PAIN |
1 |
0.0005 |
| 69 |
RETINAL OEDEMA |
1 |
0.0005 |
| 70 |
ADRENOCORTICAL INSUFFICIENCY ACUTE |
1 |
0.0005 |
| 71 |
DIPLEGIA |
1 |
0.0005 |
| 72 |
HYPERAESTHESIA |
4 |
0.0005 |
| 73 |
IMPAIRED SELF-CARE |
1 |
0.0005 |
| 74 |
DILATATION VENTRICULAR |
1 |
0.0005 |
| 75 |
OESOPHAGEAL VARICES HAEMORRHAGE |
1 |
0.0005 |
| 76 |
LACRIMATION INCREASED |
13 |
0.0004 |
| 77 |
SPINAL PAIN |
5 |
0.0004 |
| 78 |
MYOPIA |
1 |
0.0004 |
| 79 |
HAEMORRHOIDAL HAEMORRHAGE |
2 |
0.0004 |
| 80 |
METASTASES TO LIVER |
7 |
0.0004 |
| 81 |
CANCER PAIN |
1 |
0.0004 |
| 82 |
APHTHOUS ULCER |
3 |
0.0004 |
| 83 |
HEPATITIS TOXIC |
1 |
0.0004 |
| 84 |
YAWNING |
1 |
0.0004 |
| 85 |
METASTASES TO BONE |
6 |
0.0004 |
| 86 |
UPPER GASTROINTESTINAL HAEMORRHAGE |
6 |
0.0004 |
| 87 |
CARDIAC VALVE DISEASE |
2 |
0.0003 |
| 88 |
POLYNEUROPATHY |
4 |
0.0003 |
| 89 |
DERMATITIS ACNEIFORM |
2 |
0.0003 |
| 90 |
PORTAL HYPERTENSION |
1 |
0.0003 |
| 91 |
HYPERCALCAEMIA |
4 |
0.0003 |
| 92 |
LIVER DISORDER |
14 |
0.0003 |
| 93 |
HEPATITIS B REACTIVATION |
1 |
0.0003 |
| 94 |
COAGULOPATHY |
5 |
0.0003 |
| 95 |
JAUNDICE CHOLESTATIC |
1 |
0.0003 |
| 96 |
DRY EYE |
14 |
0.0003 |
| 97 |
STOMATITIS |
17 |
0.0003 |
| 98 |
METASTASIS |
2 |
0.0003 |
| 99 |
MYELODYSPLASTIC SYNDROME |
4 |
0.0003 |
| 100 |
MONOCYTE COUNT INCREASED |
1 |
0.0003 |
| 101 |
IMMUNE-MEDIATED ENTEROCOLITIS |
1 |
0.0003 |
| 102 |
BLOOD PRESSURE DIASTOLIC DECREASED |
2 |
0.0003 |
| 103 |
SENSATION OF HEAVINESS |
1 |
0.0003 |
| 104 |
CONGESTIVE CARDIOMYOPATHY |
1 |
0.0002 |
| 105 |
HEPATIC LESION |
1 |
0.0002 |
| 106 |
PARONYCHIA |
1 |
0.0002 |
| 107 |
CHRONIC KIDNEY DISEASE |
17 |
0.0002 |
| 108 |
BLOOD PRESSURE DIASTOLIC INCREASED |
1 |
0.0002 |
| 109 |
NEPHROPATHY |
2 |
0.0002 |
| 110 |
PROTEINURIA |
4 |
0.0002 |
| 111 |
DRY MOUTH |
17 |
0.0002 |
| 112 |
GASTROINTESTINAL TOXICITY |
1 |
0.0002 |
| 113 |
DISEASE PROGRESSION |
24 |
0.0002 |
| 114 |
PROTEIN URINE PRESENT |
1 |
0.0002 |
| 115 |
CARDIAC FAILURE |
16 |
0.0002 |
| 116 |
CORONARY ARTERY STENOSIS |
1 |
0.0002 |
| 117 |
MUCOSAL INFLAMMATION |
5 |
0.0002 |
| 118 |
HEPATOTOXICITY |
4 |
0.0002 |
| 119 |
GLUCOSE TOLERANCE IMPAIRED |
1 |
0.0002 |
| 120 |
NOCTURIA |
2 |
0.0002 |
| 121 |
GLOMERULAR FILTRATION RATE DECREASED |
2 |
0.0002 |
| 122 |
PRODUCT USE IN UNAPPROVED INDICATION |
40 |
0.0002 |
| 123 |
THERAPY NON-RESPONDER |
7 |
0.0002 |
| 124 |
BLOOD PRESSURE SYSTOLIC INCREASED |
3 |
0.0002 |
| 125 |
METASTASES TO LYMPH NODES |
1 |
0.0001 |
| 126 |
HUNGER |
2 |
0.0001 |
| 127 |
SEPSIS |
16 |
0.0001 |
| 128 |
DUODENAL ULCER |
1 |
0.0001 |
| 129 |
HYPOPHOSPHATAEMIA |
1 |
0.0001 |
| 130 |
HYPOAESTHESIA ORAL |
2 |
0.0001 |
| 131 |
RENAL FAILURE CHRONIC |
1 |
0.0001 |
| 132 |
MUSCULOSKELETAL CHEST PAIN |
2 |
0.0001 |
| 133 |
HYPOALBUMINAEMIA |
1 |
0.0001 |
| 134 |
THERAPY PARTIAL RESPONDER |
2 |
0.0001 |
| 135 |
TRICUSPID VALVE INCOMPETENCE |
1 |
0.0001 |
| 136 |
RHINITIS |
1 |
0.0001 |
| 137 |
EMBOLISM |
1 |
0.0001 |
| 138 |
SECOND PRIMARY MALIGNANCY |
1 |
0.0001 |
| 139 |
LYMPHOCYTE COUNT DECREASED |
2 |
0.0001 |
| 140 |
MYELOSUPPRESSION |
4 |
0.0001 |
| 141 |
OEDEMA |
6 |
0.0001 |
| 142 |
UROSEPSIS |
1 |
0.0001 |
| 143 |
RENAL IMPAIRMENT |
9 |
0.0001 |
| 144 |
TOXICITY TO VARIOUS AGENTS |
18 |
0.0001 |
| 145 |
FLANK PAIN |
1 |
0.0001 |
| 146 |
HAEMATOTOXICITY |
1 |
0.0001 |
| 147 |
LETHARGY |
6 |
0.0001 |
| 148 |
THROMBOTIC MICROANGIOPATHY |
1 |
0.0001 |
| 149 |
HAEMORRHOIDS |
2 |
0.0001 |
| 150 |
LUNG DISORDER |
5 |
0.0001 |
| 151 |
COELIAC DISEASE |
1 |
0.0001 |
| 152 |
BLOOD PRESSURE ABNORMAL |
2 |
0.0001 |
| 153 |
DECREASED APPETITE |
23 |
0.0001 |
| 154 |
EYE DISCHARGE |
1 |
0.0001 |
| 155 |
RETCHING |
2 |
0.0001 |
| 156 |
GAMMA-GLUTAMYLTRANSFERASE INCREASED |
2 |
0.0001 |
| 157 |
RASH MACULO-PAPULAR |
2 |
0.0001 |
| 158 |
MALNUTRITION |
1 |
0.0001 |
| 159 |
HEART RATE IRREGULAR |
2 |
0.0001 |
| 160 |
DRUG DEPENDENCE |
14 |
0.0001 |
| 161 |
NEOPLASM PROGRESSION |
3 |
0.0001 |
| 162 |
BONE PAIN |
5 |
0.0001 |
| 163 |
COVID-19 PNEUMONIA |
1 |
0.0001 |
| 164 |
INTERSTITIAL LUNG DISEASE |
4 |
0.0001 |
| 165 |
ADRENAL INSUFFICIENCY |
1 |
0.0001 |
| 166 |
HYPERGLYCAEMIA |
3 |
0.0001 |
| 167 |
CYTOPENIA |
1 |
0.0001 |
| 168 |
MYOCARDIAL INFARCTION |
14 |
0.0001 |
| 169 |
ASPARTATE AMINOTRANSFERASE INCREASED |
4 |
0.0001 |
| 170 |
JAUNDICE |
2 |
0.0001 |
| 171 |
FREQUENT BOWEL MOVEMENTS |
2 |
0.0001 |
| 172 |
PNEUMONITIS |
2 |
0.0001 |
| 173 |
FEELING COLD |
2 |
0.0001 |
| 174 |
WEIGHT DECREASED |
20 |
0.0001 |
| 175 |
THROMBOCYTOPENIA |
8 |
0.0001 |
| 176 |
INTERNATIONAL NORMALISED RATIO INCREASED |
2 |
0.0001 |
| 177 |
HEPATIC FAILURE |
2 |
0.0001 |
| 178 |
HIP ARTHROPLASTY |
1 |
0.0001 |
| 179 |
LYMPHOMA |
1 |
0.0001 |
| 180 |
COGNITIVE DISORDER |
3 |
0.0001 |
| 181 |
CYANOSIS |
1 |
0.0001 |
| 182 |
BLOOD LACTATE DEHYDROGENASE INCREASED |
1 |
0.0001 |
| 183 |
SCIATICA |
1 |
0.0001 |
| 184 |
PHOTOSENSITIVITY REACTION |
1 |
0.0001 |
| 185 |
EXPIRED PRODUCT ADMINISTERED |
2 |
0.0001 |
| 186 |
HAEMATURIA |
2 |
0.0001 |
| 187 |
INCORRECT ROUTE OF PRODUCT ADMINISTRATION |
1 |
0.0001 |
| 188 |
LYMPHADENOPATHY |
2 |
0.0001 |
| 189 |
RESTLESS LEGS SYNDROME |
1 |
0.0001 |
| 190 |
BLOOD GLUCOSE ABNORMAL |
1 |
0.0001 |
| 191 |
MEDICATION ERROR |
3 |
0.0001 |
| 192 |
TUBULOINTERSTITIAL NEPHRITIS |
1 |
0.0001 |
| 193 |
FLATULENCE |
3 |
0.0001 |
| 194 |
NEUTROPENIA |
7 |
0.0001 |
| 195 |
DISORIENTATION |
2 |
0.0001 |
| 196 |
FULL BLOOD COUNT DECREASED |
1 |
0.0000 |
| 197 |
OEDEMA PERIPHERAL |
6 |
0.0000 |
| 198 |
TREATMENT FAILURE |
4 |
0.0000 |
| 199 |
EATING DISORDER |
1 |
0.0000 |
| 200 |
ALTERED STATE OF CONSCIOUSNESS |
1 |
0.0000 |
| 201 |
AMNESIA |
3 |
0.0000 |
| 202 |
CONSTIPATION |
10 |
0.0000 |
| 203 |
DRUG WITHDRAWAL SYNDROME |
4 |
0.0000 |
| 204 |
MELAENA |
1 |
0.0000 |
| 205 |
ADVERSE DRUG REACTION |
4 |
0.0000 |
| 206 |
HEPATIC ENZYME INCREASED |
3 |
0.0000 |
| 207 |
FATIGUE |
34 |
0.0000 |
| 208 |
PERICARDIAL EFFUSION |
1 |
0.0000 |
| 209 |
NEUROPATHY PERIPHERAL |
4 |
0.0000 |
| 210 |
BLOOD ALKALINE PHOSPHATASE INCREASED |
1 |
0.0000 |
| 211 |
LEUKOPENIA |
2 |
0.0000 |
| 212 |
FLUID RETENTION |
2 |
0.0000 |
| 213 |
SKIN ULCER |
1 |
0.0000 |
| 214 |
PHARMACEUTICAL PRODUCT COMPLAINT |
1 |
0.0000 |
| 215 |
RENAL FAILURE |
5 |
0.0000 |
| 216 |
ASTHENIA |
14 |
0.0000 |
| 217 |
BLOOD BILIRUBIN INCREASED |
1 |
0.0000 |
| 218 |
PALLOR |
1 |
0.0000 |
| 219 |
NAUSEA |
29 |
0.0000 |
| 220 |
HAEMATOCHEZIA |
2 |
0.0000 |
| 221 |
MENTAL STATUS CHANGES |
1 |
0.0000 |
| 222 |
HAEMOPTYSIS |
1 |
0.0000 |
| 223 |
DEMENTIA |
1 |
0.0000 |
| 224 |
ANGINA PECTORIS |
1 |
0.0000 |
| 225 |
BLOOD CREATINE PHOSPHOKINASE INCREASED |
1 |
0.0000 |
| 226 |
ASCITES |
1 |
0.0000 |
| 227 |
RENAL INJURY |
1 |
0.0000 |
| 228 |
APHASIA |
1 |
0.0000 |
| 229 |
VERTIGO |
2 |
0.0000 |
| 230 |
ACUTE KIDNEY INJURY |
5 |
0.0000 |
| 231 |
ALANINE AMINOTRANSFERASE INCREASED |
2 |
0.0000 |
| 232 |
OFF LABEL USE |
28 |
0.0000 |
| 233 |
DRUG-INDUCED LIVER INJURY |
1 |
0.0000 |
| 234 |
HIP FRACTURE |
1 |
0.0000 |
| 235 |
BLOOD CREATININE INCREASED |
2 |
0.0000 |
| 236 |
CHOLELITHIASIS |
1 |
0.0000 |
| 237 |
STAPHYLOCOCCAL INFECTION |
1 |
0.0000 |
| 238 |
VOMITING |
14 |
0.0000 |
| 239 |
FLUSHING |
3 |
0.0000 |
| 240 |
DELIRIUM |
1 |
0.0000 |
| 241 |
INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION |
2 |
0.0000 |
| 242 |
INCORRECT ROUTE OF DRUG ADMINISTRATION |
1 |
0.0000 |
| 243 |
DRUG INEFFECTIVE |
35 |
0.0000 |
| 244 |
HOT FLUSH |
2 |
0.0000 |
| 245 |
BLOOD GLUCOSE INCREASED |
5 |
0.0000 |
| 246 |
INTESTINAL OBSTRUCTION |
1 |
0.0000 |
| 247 |
MUSCULAR WEAKNESS |
3 |
0.0000 |
| 248 |
DIABETES MELLITUS |
2 |
0.0000 |
| 249 |
ANAEMIA |
5 |
0.0000 |
| 250 |
GENERAL PHYSICAL HEALTH DETERIORATION |
3 |
0.0000 |
| 251 |
DRUG INTERACTION |
4 |
0.0000 |
| 252 |
THROMBOSIS |
2 |
0.0000 |
| 253 |
DIARRHOEA |
16 |
0.0000 |
| 254 |
ERYTHEMA |
5 |
0.0000 |
| 255 |
SKIN EXFOLIATION |
2 |
0.0000 |
| 256 |
RENAL FAILURE ACUTE |
1 |
0.0000 |
| 257 |
MYALGIA |
4 |
0.0000 |
| 258 |
PRODUCT STORAGE ERROR |
2 |
0.0000 |
| 259 |
TACHYCARDIA |
2 |
0.0000 |
| 260 |
PULMONARY OEDEMA |
1 |
0.0000 |
| 261 |
HYPOKALAEMIA |
1 |
0.0000 |
| 262 |
UPPER RESPIRATORY TRACT INFECTION |
1 |
0.0000 |
| 263 |
BACK PAIN |
5 |
0.0000 |
| 264 |
PRODUCT USE ISSUE |
4 |
0.0000 |
| 265 |
COMA |
1 |
0.0000 |
| 266 |
ATRIAL FIBRILLATION |
2 |
0.0000 |
| 267 |
ALOPECIA |
4 |
0.0000 |
| 268 |
HEART RATE INCREASED |
2 |
0.0000 |
| 269 |
HAEMOGLOBIN DECREASED |
2 |
0.0000 |
| 270 |
ABDOMINAL PAIN UPPER |
4 |
0.0000 |
| 271 |
ECZEMA |
1 |
0.0000 |
| 272 |
PLATELET COUNT DECREASED |
2 |
0.0000 |
| 273 |
CONFUSIONAL STATE |
3 |
0.0000 |
| 274 |
TREATMENT NONCOMPLIANCE |
1 |
0.0000 |
| 275 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
1 |
0.0000 |
| 276 |
CHILLS |
2 |
0.0000 |
| 277 |
THERAPEUTIC RESPONSE DECREASED |
1 |
0.0000 |
| 278 |
PLEURAL EFFUSION |
1 |
0.0000 |
| 279 |
DISCOMFORT |
1 |
0.0000 |
| 280 |
FEBRILE NEUTROPENIA |
1 |
0.0000 |
| 281 |
INSOMNIA |
4 |
0.0000 |
| 282 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
1 |
0.0000 |
| 283 |
RESPIRATORY FAILURE |
1 |
0.0000 |
| 284 |
AGITATION |
1 |
0.0000 |
| 285 |
DYSGEUSIA |
1 |
0.0000 |
| 286 |
HYPOAESTHESIA |
2 |
0.0000 |
| 287 |
PERIPHERAL SWELLING |
2 |
0.0000 |
| 288 |
ABDOMINAL PAIN |
3 |
0.0000 |
| 289 |
ARTHRITIS |
1 |
0.0000 |
| 290 |
PARAESTHESIA |
2 |
0.0000 |
| 291 |
CARDIAC FAILURE CONGESTIVE |
1 |
0.0000 |
| 292 |
GASTROOESOPHAGEAL REFLUX DISEASE |
1 |
0.0000 |
| 293 |
INFLUENZA LIKE ILLNESS |
1 |
0.0000 |
| 294 |
DEATH |
10 |
0.0000 |
| 295 |
RASH |
5 |
0.0000 |
| 296 |
HEADACHE |
7 |
0.0000 |
| 297 |
GASTROINTESTINAL DISORDER |
1 |
0.0000 |
| 298 |
MUSCLE SPASMS |
2 |
0.0000 |
| 299 |
CARDIAC DISORDER |
1 |
0.0000 |
| 300 |
DYSPHAGIA |
1 |
0.0000 |
| 301 |
MIGRAINE |
1 |
0.0000 |
| 302 |
GAIT DISTURBANCE |
2 |
0.0000 |
| 303 |
PAIN IN EXTREMITY |
3 |
0.0000 |
| 304 |
DYSPEPSIA |
1 |
0.0000 |
| 305 |
SYNCOPE |
1 |
0.0000 |
| 306 |
PAIN |
6 |
0.0000 |
| 307 |
ABDOMINAL DISTENSION |
1 |
0.0000 |
| 308 |
HYPERTENSION |
2 |
0.0000 |
| 309 |
WHITE BLOOD CELL COUNT DECREASED |
1 |
0.0000 |
| 310 |
INFLUENZA |
1 |
0.0000 |
| 311 |
PALPITATIONS |
1 |
0.0000 |
| 312 |
VISUAL IMPAIRMENT |
1 |
0.0000 |
| 313 |
HYPERHIDROSIS |
1 |
0.0000 |
| 314 |
DEHYDRATION |
1 |
0.0000 |
| 315 |
MEMORY IMPAIRMENT |
1 |
0.0000 |
| 316 |
ARTHRALGIA |
3 |
0.0000 |
| 317 |
COUGH |
2 |
0.0000 |
| 318 |
ANXIETY |
2 |
0.0000 |
| 319 |
INFECTION |
1 |
0.0000 |
| 320 |
INJECTION SITE PAIN |
2 |
0.0000 |
| 321 |
PNEUMONIA |
2 |
0.0000 |
| 322 |
DIZZINESS |
3 |
0.0000 |
| 323 |
CEREBROVASCULAR ACCIDENT |
1 |
0.0000 |
| 324 |
PYREXIA |
2 |
0.0000 |
| 325 |
COVID-19 |
1 |
0.0000 |
| 326 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
1 |
0.0000 |
| 327 |
CHEST PAIN |
1 |
0.0000 |
| 328 |
HYPOTENSION |
1 |
0.0000 |
| 329 |
DEPRESSION |
1 |
0.0000 |
| 330 |
FEELING ABNORMAL |
1 |
0.0000 |
| 331 |
CONDITION AGGRAVATED |
1 |
0.0000 |
| 332 |
FALL |
1 |
0.0000 |
| 333 |
MALAISE |
1 |
0.0000 |